DEF 14A

Company

Cellectar Biosciences, Inc.

Filed

April 23, 2018

Period of Report

May 31, 2018

Accession Number

0001144204-18-021824

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →